M10 BIOANALYTICAL METHOD VALIDATION AND STUDY SAMPLE ANALYSIS This guidance is intended to provide recommendations for the validation of bioanalytical methods for chemical and biological drug quantification and their application in the analysis of study
M10 Bioanalytical Method Validation and Study Sample Analysis We are in the process of retroactively making some documents accessible If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs gov
ICH HARMONISED GUIDELINE The purpose of bioanalytical method development is to define the design, operating conditions, limitations and suitability of the method for its intended purpose and to ensure that the method is ready for validation
ICH guideline M10 on bioanalytical method validation and study sample . . . The objective of the validation of a bioanalytical method is to demonstrate that it is suitable for its intended purpose Changes from the recommendations in this guideline may be acceptable if appropriate scientific justification is provided
ICH M10 Bioanalytical Method Validation Guideline-1 year Later ICH M10 provides guidance on various aspects of bioan-alytical method validation and study sample analysis Under-standing how to implement all aspects of the new guideline will be critical to ensuring the timely availability of new therapies to the global community
ICH M10 Guidance: Harmonization and Modification to Bioanalytical . . . On May 24, 2022, the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) adopted the harmonized guideline “Bioanalytical Method Validation and Study Sample Analysis M10”